Filippo T. Gallina - Publications

Multidisciplinary minimally invasive planning for synchronous breast cancer and thymoma: a scarless single-stage surgical strategy-a case report and literature review.

Journal: Gland surgery

Published: January 22, 2026

Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational Study.

Journal: Cancers

Published: January 17, 2026

Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 14, 2026

Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC.

Journal: Journal for immunotherapy of cancer

Published: January 11, 2026

Stage II Non-Small Cell Lung Cancer: Upfront Surgery or Neoadjuvant Chemoimmunotherapy.

Journal: The Annals of thoracic surgery

Published: January 06, 2026

Tumoral and Peritumoral Radiomics for Preoperative Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma.

Journal: Cancers

Published: October 29, 2025

Response to Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 24, 2025

Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-Analysis.

Journal: JTO clinical and research reports

Published: August 25, 2025

Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 20, 2025

Response to "Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients With Resectable NSCLC: Still an Open Question" by Dafni et al.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 27, 2025

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.

Journal: JAMA oncology

Published: May 22, 2025

Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Journal: Journal for immunotherapy of cancer

Published: May 01, 2025